Abstract
This clinical trial was designed to understand whether the children with juvenile osteoporosis receiving tablet containing vitamin D and calcium had lower incidence of bone fracture compared to the children receiving a diet rich in calcium, vitamin D, and protein. We assessed whether plasma levels of bone-specific alkaline phosphatase (BSAP) and procollagen I carboxyterminal propeptide levels (PIPC) could be used as predictors of early bone fracture in children. A total of 120 children of either gender with a juvenile osteoporosis were enrolled and randomized (1:1 ratio) to receive tablet containing vitamin D and calcium (n=60) or diet rich in calcium, vitamin D, and protein (n=60), and undergone follow-up for up to 3 years. Blood sample was collected and BSAP and PIPC levels were measured. The results suggested that therapeutic intervention (vitamin D and calcium) does not predict bone fracture in children. However, correlations analysis revealed that the decreased level of BSAP and PIPC were associated with higher incidence of fracture. The results suggest that the low levels of BSAP and PIPC cause increase susceptibility of fracture among children with juvenile osteoporosis. the predictive value of biomarkers in assessing an individual child has not yet been confirmed (Khoshhal, 2011) . Bone turnover markers may have a future role in the clinical management of osteoporosis.
Article Info
It is not known whether the children with juvenile osteoporosis receiving tablet containing vitamin D and calcium had lower incidence of bone fracture compared to the children receiving a diet rich in calcium, vitamin D, and protein, plays any role in predicting the bone fracture among children with juvenile osteoporosis. Also, it is not known whether plasma levels of bonespecific alkaline phosphatase (BSAP) and procollagen I carboxy-terminal propeptide levels (PIPC) could be used as predictors of early bone fracture in children. We therefore designed this interventional clinical trial to understand whether the children with juvenile osteoporosis receiving tablet containing vitamin D and calcium had lower incidence of bone fracture compared to the children receiving a diet rich in calcium, vitamin D, and protein. We also assessed whether plasma levels of bone-specific alkaline phosphatase (BSAP) and procollagen I carboxy-terminal propeptide levels (PIPC) could be used as predictors of early bone fracture in children.
Materials and Methods
In this interventional clinical trial, the children with a juvenile osteoporosis or history of bone fractures were enrolled at Trauma Department of Orthopedics, Affiliated Hospital of Chengde Medical College, China. A total of 138 patients were entered into the screening phase. Of these, a total of 120 Chinese children during January 2012 to December 2016 who were visited in our hospital at the time of their consultation were enrolled and undergone follow-up for up to 3 years. All participants underwent laboratory tests including bone mineral density or any other investigation as required investigator to confirm their eligibility for this trial. All enrolled children were enrolled and randomized to receive tablet containing vitamin D and calcium or diet rich in calcium, vitamin D, and protein, and undergone follow-up for up to 3 years in allocation ration of 1:1.
Blood samples (5 mL) were obtained from each enrolled subjects for estimation of BSAP and PIPC. Blood was collected into a tube containing potassium ethylenediamine tetraacetic acid (EDTA) and stored at less than 80°C. Venous blood sample of all the recruited subjects was drawn in syringe taking all aseptic precautions between 2 pm to 4 pm. The sample taken was kept in plain vial at room temperature before sending in to laboratory. The sample was tested for serum level of BSAP and PIPC by ELISA kit.
Since this trial was a pilot interventional clinical trial, hence, no formal sample size calculation was performed. However, at least 100 children with juvenile osteoporosis have planned to include in this trial.
Statistical analysis
Correlations between the levels of BSAP and PIPC with the incidences of fracture were done using Pearson's correlation/regression models. Statistical analysis was performed using version 6.2 of GraphPad Prism. 
Results
Of enrolled children, a total of 40 children developed at least 1 bone fracture (33.3%) during 3 year follow-up period, and remaining 80 children did not experienced any fracture. Majority of identified patients were female (female: 60%, male: 40%) with mean (SD) age of 12.2 (1.4) years. Demographic and clinical characteristic of patients are presented in Table I .
Our trial results showed that there is not statistically significant difference in fracture incidence rate between the children who received tablet containing vitamin D and calcium and the children receiving a diet rich in calcium, vitamin D, and protein (Table I ). The children who received tablet containing vitamin D and calcium had fracture incidence of 30%, whereas the children who received diet rich in calcium, vitamin D, and protein had fracture incidence of 36.7%. The difference of 6.7% between the two groups was not statistically significant (p<0.561). We also performed subgroup analysis based on the bone biomarker and fracture incidence rate of patients who received calcium and vitamin D as intervention. In this sub-group analysis, it was noted that the levels of BSAP and PIPC were significantly lesser in sub-group who had higher incidence of fracture, irrespective of therapeutic intervention (calcium and vitamin D). Correlations analysis revealed that the decreased level of BSAP (median: 8.3 µg/L) and PIPC (median: 86.0) were associated with higher incidence of fracture (Table II and III) .
Discussion
This was the first interventional clinical trial to understand whether the children with juvenile osteoporosis receiving tablet containing vitamin D and calcium had lower incidence of bone fracture compared to the children receiving a diet rich in calcium, vitamin D, and protein. Our study results showed that there was no statistical significant difference in incidence of bone fracture between children of both the groups (tablet containing vitamin D [30%] and calcium or diet rich in calcium, vitamin D, and protein [36.7%], with p= 0.561 using Chi-square test as indicated in Table I ). We also assessed whether plasma levels of BSAP and PIPC could be used as predictors of early bone fracture in children. Due to high intraindividual and interindividual variability and large discrepancy in normal values of bone biochemical markers, it is difficult to (Jensen et al., 1997a; Jensen et al., 1997b) . In addition to this, there is a large variability between analytical methods and standard from laboratory to laboratory (Jensen et al., 1997a; Jensen et al., 1997b) . Authors have concluded that large biological variability in the biochemical markers of bone turnover make them unsuitable for diagnosis for prediction of future bone loss in individual patients (Jensen et al., 1997a; Jensen et al., 1997b) . In this trial, we have used standardized method and performed all the assessment at single laboratory in order to avoid any confounding variables. Correlations analysis revealed that the decreased level of BSAP and PIPC were associated with higher incidence of fracture in the children with juvenile osteoporosis. Our trial results are in consistent with the previous reports which suggested the involvement of BSAP and PIPC in fracture (Bowles et al., 1997; Borys et al., 2001) . In contrast to this, another trial results showed that biochemical bone markers are not useful in diagnosing of osteoporosis (Nawawi et al., 2001 ). This may be due to high variability in response of enrolled patients.
Since the trial was designed as pilot trial and conducted at single center trial in China (limitation of this clinical trial). Therefore, the present findings cannot be generalized to the overall Chinese population. Our trials results encourage for conducting large multi-centric randomized clinical trial in future to generalize the findings of this trial. The hypothesis of this trial for relationship between the levels of BSAP and PIPC with the incidences of fracture was met. Overall, results showed the low levels of BSAP and PIPC causes increase susceptibility of fracture among children with juvenile osteoporosis. Thus, our trial results showed that the levels of BSAP and PIPC are one of the key predictors of early bone fracture in Chinese children with juvenile osteoporosis.
Conclusion
The results of this first pilot interventional clinical trial suggested that therapeutic intervention does not predict fracture risk in children with juvenile osteoporosis. However, the lower levels of BSAP and PIPC can be considered as predictors of fracture risk in children with juvenile osteoporosis.
Ethical Issue
The trial protocol was approved by the Ethics Committee of Chengde Medical College, China, and written informed consent was taken from each trial subjects. All subjects were educated about the trial protocol and the likely benefits to the society.
